Page last updated: 2024-10-25

ciprofloxacin and Aspergillosis, Allergic Bronchopulmonary

ciprofloxacin has been researched along with Aspergillosis, Allergic Bronchopulmonary in 1 studies

Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.

Aspergillosis, Allergic Bronchopulmonary: Hypersensitivity reaction (ALLERGIC REACTION) to fungus ASPERGILLUS in an individual with long-standing BRONCHIAL ASTHMA. It is characterized by pulmonary infiltrates, EOSINOPHILIA, elevated serum IMMUNOGLOBULIN E, and skin reactivity to Aspergillus antigen.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borlenghi, E1
Cattaneo, C1
Capucci, MA1
Pan, A1
Quaresmini, G1
Franco, F1
Grazioli, L1
Carosi, GP1
Rossi, G1

Other Studies

1 other study available for ciprofloxacin and Aspergillosis, Allergic Bronchopulmonary

ArticleYear
Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
    Annals of hematology, 2007, Volume: 86, Issue:3

    Topics: Acute Disease; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Ciprofloxac

2007